U.S. Maternal Health Devices Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2032

U.S. Maternal Health Devices Market Segmentation, By Product Type (Obstetric Devices, Fetal Monitoring Devices, Birthing Beds, Delivery Chairs, Disposable Supplies and Consumables and Others), Modality (Portable, Standalone, Handheld, Wearables, and Others), Stage (Parental Stage and Birthing Stage), Type (Point of Care Devices  and Traditional), End User (Hospital, Maternity Centers, Nursing Facilities, Specialty Clinics, Homecare Settings, and  Others), Distribution Channel (Direct Tender, Retail Sales, Online Sales, and  Others) - Industry Trends and Forecast to 2032

U.S. Maternal Health Devices Market Size

• The U.S. maternal health devices market size was valued at USD 2.75 billion in 2024 and is expected to reach USD 4.02 billion by 2032, at a CAGR of 4.90% during the forecast period
• The market growth is largely driven by increasing awareness of prenatal and postnatal care, rising maternal age, and greater access to advanced monitoring technologies in healthcare facilities
• Furthermore, growing emphasis on reducing maternal mortality rates and improving pregnancy outcomes is propelling demand for wearable, non-invasive, and remote monitoring solutions. These supportive healthcare policies and innovations are accelerating the adoption of maternal health devices, thereby significantly fueling the industry’s expansion

U.S. Maternal Health Devices Market Analysis

• Maternal health devices, encompassing fetal monitors, uterine contraction monitors, and other prenatal and postnatal care tools, are becoming essential in modern obstetric care across hospitals, clinics, and home settings due to their role in improving maternal and fetal health outcomes through continuous, real-time monitoring
• The increasing demand for maternal health devices is primarily driven by rising pregnancy-related complications, higher maternal age, and growing awareness around early detection and intervention for maternal and fetal risks
• A significant factor influencing market growth in the U.S. is the national emphasis on improving maternal health outcomes through federal initiatives such as the HHS Maternal Health Blueprint and expanded telehealth coverage under Medicaid, which are boosting access to advanced maternal care technologies
• Technological advancements such as wireless fetal monitoring, AI-enabled diagnostics, and smartphone-connected devices are enhancing care delivery, enabling early detection of high-risk pregnancies, and supporting personalized maternal care
• Fetal monitoring devices dominated the U.S. maternal health devices market with a share of 46.8% in 2024, attributed to their critical role in continuously assessing fetal well-being and preventing complications during labor and delivery

Report Scope and U.S. Maternal Health Devices Market Segmentation         

U.S. Maternal Health Devices Market Trends

“Rising Integration of Remote Monitoring and Digital Health Platforms”

• A significant and accelerating trend in the U.S. maternal health devices market is the growing integration of remote monitoring technologies and digital health platforms, enabling continuous care outside of clinical settings. This shift is enhancing accessibility, especially for high-risk pregnancies and underserved populations
• For instance, companies such as Nuvo Group offer FDA-cleared wearable fetal monitoring devices (such as INVU) that allow physicians to remotely track vital maternal and fetal data, reducing the need for frequent in-person visits
• These digital platforms, often connected to mobile apps, enable real-time sharing of health metrics such as fetal heart rate, uterine activity, and maternal vitals, allowing for prompt intervention and improved outcomes. This is particularly beneficial for rural or low-access areas where regular clinic visits may be limited
• The trend is also supported by policy-level initiatives, including expanded Medicaid reimbursement for remote maternity care and prenatal telehealth services under CMS guidelines, reflecting strong governmental support for technology-enabled maternal care
• Integrated solutions combining wearable sensors, AI analytics, and cloud-based dashboards are redefining maternity care models. Companies such as Bloomlife and HeraBEAT are driving innovation by focusing on user-friendly, at-home monitoring devices that meet clinical standards
• The shift towards connected maternal health devices is aligning with broader healthcare digitalization goals, promoting continuous, patient-centric care and reshaping expectations for prenatal and postnatal management in the U.S.

U.S. Maternal Health Devices Market Dynamics

Driver

“Improving Maternal Outcomes through Advanced Monitoring and Federal Support”

• The growing concern over maternal mortality and pregnancy-related complications in the U.S. has spurred demand for advanced maternal health devices capable of continuous, accurate monitoring during the prenatal, intrapartum, and postpartum phases
• For instance, the U.S. Department of Health and Human Services (HHS) launched the Maternal Health Blueprint to reduce maternal mortality by expanding access to monitoring tools, telehealth, and home-based care, particularly in underserved communities
• Devices such as fetal heart rate monitors, uterine activity sensors, and wireless blood pressure cuffs are increasingly utilized in hospitals and at home to manage high-risk pregnancies, detect early warning signs, and guide timely interventions
• Growing adoption of personalized maternal care through data-driven monitoring and the availability of connected solutions are key drivers transforming traditional obstetric care into a tech-enabled, proactive model
• Furthermore, the focus on value-based care, combined with incentives for remote patient monitoring under Medicare and Medicaid, is boosting the integration of smart maternal devices into everyday clinical practice

Restraint/Challenge

“High Equipment Costs and Data Privacy Concerns”

• Despite growing awareness, the high cost of advanced maternal monitoring devices and limited insurance coverage for certain at-home tools pose financial barriers for broad adoption, particularly among lower-income populations
• For instance, while wearable fetal monitors such as INVU offer convenience, their price points can be prohibitive for uninsured or underinsured patients, leading to disparities in access to quality maternal care
• In addition, maternal health devices that collect, store, and transmit sensitive data face challenges related to HIPAA compliance and cybersecurity. Concerns around unauthorized data access, particularly in remote or cloud-connected systems, have made some providers cautious about full-scale adoption
• Addressing these barriers will require collaborative efforts between manufacturers, payers, and policymakers to develop affordable, secure, and scalable solutions
• Enhancing public trust through transparent data handling, improved affordability, and insurance reimbursement pathways will be critical for ensuring equitable access and driving long-term market growth

U.S. Maternal Health Devices Market Scope

The market is segmented on the basis of product type, modality, stage, type, end user, and distribution channel.

• By Product Type

On the basis of product type, the U.S. maternal health devices market is segmented into obstetric devices, fetal monitoring devices, birthing beds, delivery chairs, disposable supplies and consumables, and others. The fetal monitoring devices segment dominated the market with the largest market revenue share of 46.8% in 2024, attributed to their widespread use in continuously assessing fetal well-being during labor and prenatal check-ups. The demand for these devices is driven by rising pregnancy complications, the need for real-time monitoring, and growing hospital births requiring advanced fetal surveillance systems.

The disposable supplies and consumables segment is anticipated to witness the fastest growth rate from 2025 to 2032, fueled by increasing concerns over infection control, rising outpatient procedures, and the growing use of single-use items in both clinical and homecare settings. Products such as fetal electrodes, maternal drapes, and diagnostic consumables are experiencing strong demand due to their ease of use and regulatory emphasis on hygiene.

• By Modality

On the basis of modality, the U.S. maternal health devices market is segmented into portable, standalone, handheld, wearables, and others. The standalone segment held the largest market revenue share in 2024, supported by their strong presence in hospital settings where continuous, high-accuracy monitoring is crucial for managing high-risk pregnancies and deliveries.

The wearables segment is anticipated to witness the fastest growth rate from 2025 to 2032, driven by rising demand for remote monitoring and telehealth integration. Wearable maternal devices allow real-time data tracking of fetal and maternal vitals, offering convenience, early detection of risks, and enhanced patient engagement, especially in homecare settings.

• By Stage

On the basis of stage, the U.S. maternal health devices market is segmented into parental stage and birthing stage. The birthing stage segment dominated the market with the largest revenue share in 2024, driven by increasing childbirths in clinical settings and the high usage of delivery beds, fetal monitors, and uterine contraction monitors during labor. Hospitals and maternity centers are equipping labor wards with advanced devices to improve birth outcomes and manage complications.

The parental stage segment is expected to witness notable growth over the forecast period, supported by the rising use of portable and wearable devices for prenatal screening and monitoring at home or in outpatient settings.

• By Type

On the basis of type, the U.S. maternal health devices market is segmented into point of care devices and traditional. The point of care devices segment dominated the market in 2024 due to the growing adoption of compact, digitally enabled diagnostic and monitoring devices that provide real-time insights. These devices are increasingly integrated into mobile health platforms and teleconsultations, particularly useful in underserved and rural regions.

The traditional segment is expected to grow at a fastest pace during forecast period, as healthcare providers and patients shift toward more advanced, connected maternal care technologies that offer higher accuracy, convenience, and remote monitoring capabilities.

• By End User

On the basis of end user, the U.S. maternal health devices market is segmented into hospitals, maternity centers, nursing facilities, specialty clinics, homecare settings, and others. The hospital segment dominated the market in 2024 with the largest revenue share, supported by high delivery volumes, greater access to advanced technologies, and skilled obstetric care. Hospitals remain the primary setting for high-risk pregnancies and labor management.

The homecare settings segment is anticipated to witness the fastest growth rate from 2025 to 2032, fueled by the increasing popularity of at-home prenatal care, wearable maternal monitoring devices, and the shift toward patient-centered maternity models enabled by digital health platforms.

• By Distribution Channel

On the basis of distribution channel, the U.S. maternal health devices market is segmented into direct tender, retail sales, online sales, and others. The direct tender segment held the largest market revenue share in 2024, as most hospitals and healthcare institutions procure maternal care equipment through government and bulk purchase agreements to support maternity wards and labor rooms.

The online sales segment is expected to witness the fastest growth rate from 2025 to 2032, driven by growing consumer awareness, the increasing adoption of home-based monitoring solutions, and the availability of maternal health devices through e-commerce platforms and telehealth providers.

U.S. Maternal Health Devices Market Share

The U.S. maternal health devices industry is primarily led by well-established companies, including:

• Koninklijke Philips N.V. (Netherlands)
• GE HealthCare (U.S.)
• Medtronic (Ireland)
• Stryker (U.S.)
• Hologic, Inc. (U.S.)
• CooperSurgical, Inc. (U.S.)
• Fujifilm Sonosite, Inc. (U.S.)
• BD (U.S.)
• Nuvo Group Ltd. (Israel)
• Abbott (U.S.)
• Edan Instruments, Inc. (China)
• Tristel Solutions Limited (U.K.)
• Dixion Vertrieb medizinischer Geräte GmbH (Germany)
• Bionet Co., Ltd. (South Korea)
• Promed Group Co., Ltd. (China)
• Lifeline Biomedics Pvt. Ltd. (India)

What are the Recent Developments in U.S. Maternal Health Devices Market?

• In May 2024, Philips North America announced the deployment of its next-generation Avalon CL Wireless Fetal Monitoring System across several U.S. maternity hospitals. This cable-free technology allows continuous monitoring of maternal and fetal vitals while enabling greater mobility during labor. The launch aligns with growing demand for patient-centered birthing experiences and underscores Philips' leadership in advanced, connected maternal care solutions
• In April 2024, Nuvo Group expanded its partnership with major U.S. health systems to scale adoption of its INVU remote monitoring platform for pregnancy care. The FDA-cleared wearable device allows real-time tracking of fetal heart rate and maternal vitals from home, enhancing prenatal care access for high-risk and rural populations. This collaboration demonstrates Nuvo’s commitment to democratizing maternal healthcare through telehealth innovation
• In March 2024, GE HealthCare introduced enhanced features for its Corometrics 259cx maternal and fetal monitoring system, now including improved AI-driven analytics for early warning detection during labor. Deployed in leading U.S. hospitals, the system reflects the industry's push toward data-enhanced decision support tools that reduce labor-related complications and improve birth outcomes
• In February 2024, Bloomlife, a maternal health tech startup based in the U.S., received additional Series A funding to accelerate the development of its wearable contraction tracker and prenatal monitoring platform. Designed for home use, the device utilizes biosensor technology and cloud analytics to track uterine activity. This innovation supports the growing trend toward self-managed maternal health and remote patient monitoring
• In January 2024, Monica Healthcare, a subsidiary of GE HealthCare, reported expanded use of its Novii Wireless Patch System in maternity clinics across the U.S. The device offers non-invasive, wireless monitoring of fetal heart rate, maternal heart rate, and uterine activity. Its increased adoption reflects the market’s shift toward mobility, comfort, and continuous monitoring in labor and delivery environments

SKU-70424